-
Loading metrics
Open Access
Peer-reviewed
Research Article
SLC2A9 Is a High-Capacity Urate Transporter in Humans
-
Mark J Caulfield ,
Contributed equally to this work with: Mark J Caulfield, Patricia B Munroe
*To whom correspondence should be addressed. E-mail: m.j.caulfield@qmul.ac.uk
Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom
⨯ -
Patricia B Munroe ,
Contributed equally to this work with: Mark J Caulfield, Patricia B Munroe
Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom
⨯ -
Deb O'Neill,
Affiliation Department of Physiology, University of Alberta, Edmonton, Alberta, Canada
⨯ -
Kate Witkowska,
Affiliation Department of Physiology, University of Alberta, Edmonton, Alberta, Canada
⨯ -
Fadi J Charchar,
Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom
⨯ -
Manuel Doblado,
Affiliation Department of Obstetrics and Gynaecology, Washington University in St Louis School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Sarah Evans,
Affiliation Department of Obstetrics and Gynaecology, Washington University in St Louis School of Medicine, St. Louis, Missouri, United States of America
⨯ -
Susana Eyheramendy,
Affiliation Department of Statistics, Pontificia Universidad Católica de Chile, Santiago, Chile
⨯ -
Abiodun Onipinla,
Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom
⨯ -
Philip Howard,
Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom
⨯ -
Sue Shaw-Hawkins,
Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom
⨯ -
Richard J Dobson,
Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom
⨯ -
Chris Wallace,
Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom
⨯ -
Stephen J Newhouse,
Affiliation Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom
⨯ -
Morris Brown,
Affiliation Clinical Pharmacology Unit, University of Cambridge, Addenbrookes Hospital, Cambridge, United Kingdom
⨯ -
John M Connell,
Affiliation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom
⨯ -
Anna Dominiczak,
Affiliation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom
⨯ -
Martin Farrall,
Affiliation Cardiovascular Medicine, University of Oxford, Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom
⨯ -
G. Mark Lathrop,
Affiliation Centre National de Génotypage, Evry, France
⨯ -
Nilesh J Samani,
Affiliations Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, United Kingdom , Epidemiology and Public Health, University College, London, United Kingdom
⨯ -
Meena Kumari,
Affiliation Epidemiology and Public Health, University College, London, United Kingdom
⨯ -
Michael Marmot,
Affiliation Epidemiology and Public Health, University College, London, United Kingdom
⨯ -
Eric Brunner,
Affiliation Epidemiology and Public Health, University College, London, United Kingdom
⨯ -
John Chambers,
Affiliation National Heart Lung Institute and Epidemiology and Public Health, Imperial College, London, United Kingdom
⨯ -
Paul Elliott,
Affiliation National Heart Lung Institute and Epidemiology and Public Health, Imperial College, London, United Kingdom
⨯ -
Jaspal Kooner,
Affiliation National Heart Lung Institute and Epidemiology and Public Health, Imperial College, London, United Kingdom
⨯ -
Maris Laan,
Affiliation Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia
⨯ -
Elin Org,
Affiliation Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia
⨯ -
Gudrun Veldre,
Affiliations Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia , Department of Cardiology, University of Tartu, Tartu, Estonia
⨯ -
Margus Viigimaa,
Affiliation Centre of Cardiology, North Estonia Medical Centre, Tallinn, Estonia
⨯ -
Francesco P Cappuccio,
Affiliation Cardiovascular Medicine and Epidemiology, Clinical Sciences Research Institute, University of Warwick Medical School, Clifford Bridge Road, Coventry, United Kingdom
⨯ -
Chen Ji,
Affiliation Cardiovascular Medicine and Epidemiology, Clinical Sciences Research Institute, University of Warwick Medical School, Clifford Bridge Road, Coventry, United Kingdom
⨯ -
Roberto Iacone,
Affiliation Department of Clinical and Experimental Medicine, Federico II University of Naples Medical School, Naples, Italy
⨯ -
Pasquale Strazzullo,
Affiliation Department of Clinical and Experimental Medicine, Federico II University of Naples Medical School, Naples, Italy
⨯ -
Kelle H Moley,
Affiliation Department of Obstetrics and Gynaecology, Washington University in St Louis School of Medicine, St. Louis, Missouri, United States of America
⨯ - [ ... ],
-
Chris Cheeseman
Affiliation Department of Physiology, University of Alberta, Edmonton, Alberta, Canada
⨯ - [ view all ]
- [ view less ]
SLC2A9 Is a High-Capacity Urate Transporter in Humans
- Mark J Caulfield,
- Patricia B Munroe,
- Deb O'Neill,
- Kate Witkowska,
- Fadi J Charchar,
- Manuel Doblado,
- Sarah Evans,
- Susana Eyheramendy,
- Abiodun Onipinla,
- Philip Howard
- Published: October 7, 2008
- https://doi.org/10.1371/journal.pmed.0050197